Vetr upgraded shares of Danaher Co. (NYSE:DHR) from a buy rating to a strong-buy rating in a report released on Thursday. Vetr currently has $94.18 target price on the conglomerate’s stock.

Other equities research analysts also recently issued reports about the company. Deutsche Bank AG reaffirmed a buy rating and set a $88.00 price objective on shares of Danaher in a report on Wednesday, January 18th. Zacks Investment Research downgraded Danaher from a buy rating to a hold rating in a report on Thursday, December 29th. Evercore ISI lifted their price objective on Danaher from $88.50 to $91.50 and gave the company a buy rating in a report on Tuesday, January 31st. Jefferies Group LLC lifted their price objective on Danaher from $93.00 to $95.00 and gave the company a buy rating in a report on Wednesday, February 1st. Finally, Citigroup Inc raised Danaher from a neutral rating to a buy rating and set a $98.00 price objective on the stock in a report on Friday, February 24th. Four analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Danaher presently has a consensus rating of Buy and a consensus price target of $93.92.

Analyst Recommendations for Danaher (NYSE:DHR)

Shares of Danaher (NYSE:DHR) traded down 1.41% during midday trading on Thursday, reaching $81.72. The company’s stock had a trading volume of 5,453,283 shares. The stock has a market capitalization of $56.65 billion, a P/E ratio of 22.38 and a beta of 1.00. The stock’s 50-day moving average is $86.21 and its 200 day moving average is $81.56. Danaher has a 12 month low of $72.34 and a 12 month high of $102.79.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 20th. The conglomerate reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.01. The company had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $4.17 billion. Danaher had a return on equity of 12.38% and a net margin of 12.84%. The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.08 earnings per share. On average, analysts expect that Danaher will post $3.95 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Danaher Co. (DHR) Upgraded by Vetr Inc. to Strong-Buy” was reported by Financial Market News and is the sole property of of Financial Market News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at http://www.financial-market-news.com/danaher-co-dhr-upgraded-by-vetr-inc-to-strong-buy/1406027/.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, March 31st will be given a dividend of $0.14 per share. This is a boost from Danaher’s previous quarterly dividend of $0.13. The ex-dividend date is Wednesday, March 29th. This represents a $0.56 annualized dividend and a dividend yield of 0.68%. Danaher’s payout ratio is presently 13.66%.

In other Danaher news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction on Tuesday, February 14th. The shares were sold at an average price of $83.98, for a total transaction of $888,340.44. Following the completion of the sale, the director now owns 95,378 shares in the company, valued at approximately $8,009,844.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Robert S. Lutz sold 37,870 shares of the company’s stock in a transaction on Friday, February 24th. The shares were sold at an average price of $85.60, for a total transaction of $3,241,672.00. Following the sale, the senior vice president now owns 27,475 shares of the company’s stock, valued at approximately $2,351,860. The disclosure for this sale can be found here. Insiders have sold a total of 60,009 shares of company stock valued at $5,106,487 in the last quarter. Corporate insiders own 12.60% of the company’s stock.

Several hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of Danaher during the fourth quarter valued at approximately $465,363,000. Dodge & Cox acquired a new stake in shares of Danaher during the fourth quarter valued at approximately $406,424,000. Fred Alger Management Inc. boosted its stake in shares of Danaher by 676.9% in the fourth quarter. Fred Alger Management Inc. now owns 1,637,360 shares of the conglomerate’s stock valued at $127,452,000 after buying an additional 1,426,599 shares during the last quarter. State Street Corp boosted its stake in shares of Danaher by 5.2% in the fourth quarter. State Street Corp now owns 24,796,803 shares of the conglomerate’s stock valued at $1,930,189,000 after buying an additional 1,232,416 shares during the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new stake in shares of Danaher during the fourth quarter valued at approximately $90,178,000. Institutional investors own 76.14% of the company’s stock.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

5 Day Chart for NYSE:DHR

To view Vetr’s full report, visit Vetr’s official website.

Receive News & Ratings for Danaher Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Co. and related companies with MarketBeat.com's FREE daily email newsletter.